Summit Therapeutics (NASDAQ:SMMT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Summit Therapeutics Stock (NASDAQ: SMMT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	50.34K / 2.22M
Day Range	- - -
52 Wk Range	2.10 - 33.89
Market Cap	$16.79B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	17.55%
Days to Cover	8.31

Recent News

Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?

All three major U.S. stock indices are down Friday as traders reacted to several sets of fresh data that raised concerns about the economic outlook.

Erica Kollmann

Jim Cramer Says AppFolio Is A 'Good One,' But Summit Therapeutics? 'Can't Go There'

On CNBC's "Mad Money Lightning Round," Jim Cramer said Summit Therapeutics is "obviously just a very big spec."

Avi Kapoor

Netflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?

12 large-cap stocks saw significant gains last week, including Summit Therapeutics, Rocket Lab, Moderna, and Netflix. Analysts raised price forecasts.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	50.34K / 2.22M
Day Range	- - -
52 Wk Range	2.10 - 33.89
Market Cap	$16.79B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	17.55%
Days to Cover	8.31

About Summit Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Summit Therapeutics (SMMT) stock?

You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.

View our list of the best stock brokerages

Who are Summit Therapeutics (SMMT) competitors?

Other companies in Summit Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Summit Therapeutics (SMMT) stock?

Summit Therapeutics has a consensus price target of $33.57.

What is the current price for Summit Therapeutics (SMMT)?

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $22.77 last updated February 24, 2025 at 7:15 AM EST.

Does Summit Therapeutics (SMMT) pay a dividend?

There are no upcoming dividends for Summit Therapeutics.

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

Summit Therapeutics’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Summit Therapeutics (SMMT) going to split?

There is no upcoming split for Summit Therapeutics.

What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Summit Therapeutics

Summit Therapeutics (SMMT) Forecast